NDC 0008-2001-01 - Protonix I.V.
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0008-2001
- Requested NDC
- 0008-2001-01
- Package NDCs from labels
- 0008-2001-01, 0008-2001-25, 0008-2001-10
- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC
- Effective date
- 2022-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC | 2022-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0008-2001-01 | EA - Each | 0008-2001 | ad389b07-7de3-422f-b0ff-7201c7e3a0c0 | 1 | 2014-04-03 |
| 0008-2001-10 | EA - Each | 0008-2001 | bda3bf5d-8674-4692-b11d-f8e080e04d1c | 1 | 2014-04-03 |
| 0008-2001-25 | EA - Each | 0008-2001 | 5d5925d0-ec2a-4b9a-aa1c-c0909dde694b | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | ACTIVE INGREDIENT | 6871619Q5X | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| PANTOPRAZOLE | ACTIVE MOIETY | D8TST4O562 | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | A-S Medication Solutions | 81696241-17d5-4d35-9e59-8c28469ffd2c | 2025-03-14 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Meitheal Pharmaceuticals Inc. | c18aff31-f91e-4b6a-9713-52c9094c6082 | 2025-03-13 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | BE Pharmaceuticals Inc. | 52d5bc28-66df-43aa-bb1a-8ac4a2a7f693 | 2025-03-07 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | NuCare Pharmaceuticals,Inc. | 07ff83f9-7039-ac26-e063-6394a90a37ce | 2025-02-03 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NuCare Pharmaceuticals,Inc. | 8aac1642-6cb0-6ad2-e053-2a95a90a4cbd | 2025-01-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | NuCare Pharmaceuticals, Inc. | 2bed1bae-519f-1bb9-e063-6294a90a795b | 2025-01-29 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | d9fcf6a2-3788-4955-84d9-3c319b13267c | 2025-01-22 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | DIRECT RX | a7e7c1ab-3e75-1ff8-e053-2995a90a7539 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx of Tennessee, LLC | b3277cb8-26d0-bce0-e053-2a95a90af6dd | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | c89a5396-1d94-c7fa-e053-2995a90a9063 | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | bd4759ac-46b5-6903-e053-2a95a90a6319 | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | d27e1fdd-e23f-0d60-e053-2a95a90a9087 | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx Pharmacy of Tennessee, LLC | f5c9e3c6-d4b0-0ebe-e053-2995a90abe55 | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Fresenius Kabi USA, LLC | 340b57c2-bcf8-4f46-b522-886daaf80351 | 2024-12-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Quality Care Products, LLC | a9fbf3b5-ddf4-4d3a-8b69-a0c38b3fa5e2 | 2024-12-19 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Civica, Inc. | c857dc41-7b47-4f26-a9f5-d76eb82b44ee | 2024-10-31 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | NuCare Pharmaceuticals,Inc. | a9f32edf-e0b9-4e96-e053-2a95a90afbc8 | 2024-10-02 | Boxed warning, Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | American Health Packaging | 423dac8b-bb1e-4456-9b6e-913c028b11bc | 2024-10-01 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | NorthStar RxLLC | 4494f9d0-a1c8-477f-9b4a-f65d7637d9ec | 2024-08-14 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | NuCare Pharmaceuticals,Inc. | b2abc159-e450-99dc-e053-2a95a90abe6a | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.